학술논문
A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
Document Type
Letter
Source
Journal of Neuro-Oncology; Aug2019, Vol. 144 Issue 1, p235-237, 3p
Subject
Language
ISSN
0167594X